clinical trial · NCT03665285
A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors
Advanced or Metastatic Solid TumorsLung CancerBreast CancerHead and Neck Squamous Cell CarcinomaEndometrial CancerMelanomaCRCUrothelial CarcinomaNC318
brief summary
This research study is studying a new drug, NC318, as a possible treatment for advanced or metastatic solid tumors.
started
Oct 1, 2018
primary completion
Apr 11, 2023
completion
Apr 11, 2023
last updated
Mar 8, 2024
official title
A Phase 1/2, Open-Label, Dose-Escalation, Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol